R/R DLBCL: Safety Considerations for Bispecific Antibodies

A comprehensive overview of safety considerations for bispecific antibodies in patients treated for R/R DLBCL.

Related Keywords

,New Treatment Options ,Sequencing Therapeutic Choices ,Safety Considerations ,Lymphoma ,Dlbcl ,Diffuse Largeb Cell Lymphoma ,Dlbcl Treatments ,Dlbcl Therapies ,Dlbcl Unmet Needs ,